Preclinical Trials in White Mice and Rabbits of the Improved “Associated Inactivated Emulsion Vaccine against Infectious Bovine Rhinotracheitis (IBR), Bovine Viral Diarrhea/Mucosal Disease (BVD), Bovine Parainfluenza Virus 3 (BPIV-3) and Chlamydia in Cattle”

Introduction. Infectious respiratory and intestinal diseases in cattle are multifactorial diseases, which explains the associated viral or viral-bacterial etiology of the infection among productive livestock. Combating associated respiratory and intestinal infections in cattle is carried in the vast majority of countries in the world and requires efficient measures and medications. The aim of the present research is conducting the preclinical trials in white mice and rabbits of the experimental series of the “Associated inactivated emulsion vaccine against IBR, BVD, BPIV-3 and chlamydia in cattle” improved by expanding the chlamydial antigen spectrum.
Materials and Methods. The trials were conducted in the Animal Viral Disease Laboratory of the Federal Center for Toxicological, Radiation, and Biological Safety (Kazan) from February to November 2024. Two versions of the biopharmaceutical were produced: a standard associated vaccine and an experimental vaccine with the AMK-16 and MZ-89 strains added to the chlamydial antigen. White mice and rabbits served as laboratory animals. The vaccines were evaluated for sterility, safety, tolerability, antigenic activity, impact on antiviral humoral immunity and immunogenicity.
Results. Both versions of the associated vaccine had proved to be sterile, harmless, and well-tolerated by laboratory animals. Changing the chlamydial antigen composition of the associated vaccine did not have an adverse effect on the development of antiviral humoral immunity in laboratory animals. The level of specific anti-chlamydial antibodies in rabbits vaccinated with the improved vaccine was higher than in the group of rabbits vaccinated with the standard technology vaccine. The protection index in the group of white mice vaccinated with the improved vaccine was 1.3 times higher than that with the standard vaccine.
Discussion and Conclusion. Based on the data obtained, it can be concluded that the improved associated vaccine, the same as the standard one, is well tolerated by laboratory animals. Expansion of the chlamydial antigen spectrum of the “Associated vaccine against IBR, BVD, BPIV-3 and Chlamydia in cattle” by adding additional strains did not have any negative effect on the development of antiviral humoral immunity in laboratory animals, but on the contrary had stimulated the development of a humoral response to the chlamydial antigen, thus, boosting the vaccine immunogenicity by 1.3 times.

1. Murray GM, Cassidy JP, Clegg TA, Tratalos JA, McClure J, O’Neill RG, et al. A Retrospective Epidemiological Analysis of Risk Factors for a Primary Necropsy Diagnosis of Bovine Respiratory Disease. Preventive Veterinary Medicine. 2016;132:49–56. https://doi.org/10.1016/j.prevetmed.2016.08.009

2. Callaby R, Toye P, Jennings A, Thumbi SM, Coetzer JA, Conradie Van Wyk IC, et al. Seroprevalence of Respiratory Viral Pathogens of Indigenous Calves in Western Kenya. Research in Veterinary Science. 2016;108:120–124. https://doi:10.1016/j.rvsc.2016.08.010

3. Притыченко А.В., Красочко И.А. Иммуногенность инактивированной ассоциированной вакцины против вирусных респираторных инфекций крупного рогатого скота. В: Материалы Международной научно-практической конференции, посвященной Дню Белорусской науки и 95-летию кафедры эпизоотологии и инфекционных болезней. Витебск; 2023. С. 95–97.

4. Murray GM, O'Neill RG, More SJ, McElroy MC, Earley B, Cassidy JP. Evolving Views on Bovine Respiratory Disease: An Appraisal of Selected Control Measures – Part 2. The Veterinary Journal. 2016;217:78–82. https://doi.org/10.1016/j.tvjl.2016.09.013

5. Bell RL, Turkington HL, Cosby SL. The Bacterial and Viral Agents of BRDC: Immune Evasion and Vaccine Developments. Vaccines. 2021;9(4):337. https://doi.org/10.3390/vaccines9040337

6. Grissett GP, White BJ, Larson, RL. Structured Literature Review of Responses of Cattle to Viral and Bacterial Pathogens Causing Bovine Respiratory Disease Complex. Journal of Veterinary Internal Medicine. 2015;29(3):770–780. https://doi.org/10.1111/jvim.12597

7. Brodersen BW, Kelling CL. Effect of Concurrent Experimentally Induced Bovine Respiratory Syncytial Virus and Bovine Viral Diarrhea Virus Infection on Respiratory Tract and Enteric Diseases in Calves. American Journal of Veterinary Research. 1998;59(11):1423–1430.

8. Woolums AR, Ames TR, Baker JC. The Bronchopneumonias (Respiratory Disease Complex of Cattle, Sheep, and Goats). In: Large Animal Internal Medicine; Louis, MO: Mosby Elsevier; 2015. P. 584–603.

9. Красочко П.А., Красочко П.П., Иващенко И.А. Изучение безвредности различных вариантов ассоциированной вирусно-бактериальной вакцины. В: Материалы Международной научно-практической конференции, посвященной 95-летию со дня рождения доктора ветеринарных наук, профессора Смирновой Нины Ивановны и Дню белорусской науки. Витебская государственная академия ветеринарной медицины: Витебск; 2024. С. 79–84.

10. Глотов А.Г., Глотова Т.И., Нефедченко А.В. Этиологическая структура массовых респираторных болезней молодняка крупного рогатого скота в хозяйствах, занимающихся производством молока. Сибирский вестник сельскохозяйственной науки. 2008;(3(183)):72–78.

11. Федорова В.А., Ляпина А.М., Хижнякова М.А., Зайцев С.С., Салтыков Ю.В., Субботина И.А. и др. Хламидиозы животных и человека. Москва: Наука; 2019. 135 с.

12. Мустафаева Н.А., Сафарова С.А., Джумшудова Ф.А. Бабанлы Л.Т., Мамедова М.A. Хламидиоз сельскохозяйственных животных. Прикаспийский вестник ветеринарии. 2023;(1(2)):24–28.

13. Равилов А.З., Гаффаров Х.З., Равилов Р.Х. Хламидиоз животных. Монография. Казань: Издательство «Фэн» Академии наук Республики Татарстан, 2004. 368 с.

14. Borel N, Sachse K. Zoonotic Transmission of Chlamydia Spp.: Known for 140 Years, but Still Underestimated. In book: Sing A. (Ed.) Zoonoses: Infections Affecting Humans and Animals. Cham: Springer; 2023. P. 1–28. https://doi.org/10.1007/978-3-030-85877-3_53-1

15. Акбашев И.Р. Усовершенстование средств специфической профилактики вирусно-хламидийных инфекций крупного рогатого скота. Дис. канд. ветеринар. наук. Казань; 2021. 129 с.

16. Евстифеев В.В., Гумеров В.Г., Хусаинов Ф.М. Каримуллина И.Г., Акбашев И.Р., Яковлев С.И. и др. Разработка ассоциированной вакцины против ИРТ, ПГ-3, ВД-БС и хламидиоза крупного рогатого скота. Ветеринарный врач. 2020;(6):21–28. https://doi.10.33632/1998-698X.2020-6-21-28

17. Яковлев С.И. Усовершенствование средств специфической профилактики хламидиоза животных. Дис. канд. ветеринар. наук. Москва; 2022. 138 с.

18. Feodorova VA, Zaitsev SS, Khizhnyakova MA, Saltykov YuV, Evstifeev VV, Khusainov FM, et al. Data of de Novo Genome Assembly of the Chlamydia Psittaci Strain Isolated from the Livestock in Volga Region, Russian Federation. Data Brief; 2020;29:105190. https://doi.10.1016/j.dib.2020.105190

19. Евстифеев В.В. Разработка и усовершенствование биологических препаратов для диагностики и специфической профилактики хламидиоза животных. Дис. доктор. биолог. наук. Казань; 2015. 417 с.

20. Zaitsev S, Khizhnyakova M, Saltykov Yu, Evstifeev V, Khusainov F, Ivanova S, et al. Complete Genome Sequence of Chlamydia Psittaci АМК-16, Isolated from a Small Ruminant in the Middle Volga Region, Russia. Microbiology Resource Announcements: 2024;13(5):e0054323. https://doi.10.1128/mra.00543-23

21. Feodorova VA, Zaitsev SS, Lyapina AM, Kichemazova NV, Saltykov YuV, et al. Whole Genome Sequencing Characteristics of Chlamydia Psittaci Caprine AMK-16 Strain, a Promising Killed Whole Cell Veterinary Vaccine Candidate against Chlamydia Infection. PLoS ONE. 2023;18(10):e0293612. (In Russ.) https://doi.10.1371/journal.pone.0293612